(NYSE: SCL) Stepan Co's forecast annual revenue growth rate of 8.17% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.65%.
Stepan Co's revenue in 2025 is $2,260,395,000.On average, 1 Wall Street analysts forecast SCL's revenue for 2025 to be $53,069,476,460, with the lowest SCL revenue forecast at $53,069,476,460, and the highest SCL revenue forecast at $53,069,476,460.
In 2026, SCL is forecast to generate $57,959,150,788 in revenue, with the lowest revenue forecast at $57,959,150,788 and the highest revenue forecast at $57,959,150,788.